Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V9NE
|
||||
Former ID |
DNC002674
|
||||
Drug Name |
Tanaproget
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Estrogen deficiency [ICD10:E28.39] | Investigative | [542440] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15N3OS
|
||||
InChI |
InChI=1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21)
|
||||
InChIKey |
PYVFWTPEBMRKSR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | Inhibitor | [551374] | |
KEGG Pathway | Oocyte meiosis | ||||
Progesterone-mediated oocyte maturation | |||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.